Filing Details

Accession Number:
0001213900-25-016266
Form Type:
13G Filing
Publication Date:
2025-02-23 19:00:00
Filed By:
Dr. Finian Tan
Company:
Aardvark Therapeutics Inc.
Filing Date:
2025-02-24
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Dr. Finian Tan 0 1,828,258 8.69%
Christopher Michael Ho 0 1,694,894 7.92%
Vickers Venture Fund VI Pte. Ltd. 0 2,050,902 9.58%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
Dr. Finian Tan
 
Signature:/s/ Dr. Finian Tan
Name/Title:Dr. Finian Tan
Date:02/24/2025
 
Christopher Michael Ho
 
Signature:/s/ Christopher Michael Ho
Name/Title:Christopher Michael Ho
Date:02/24/2025
 
Vickers Venture Fund VI Pte. Ltd.
 
Signature:/s/ Dr. Jeffrey Chi
Name/Title:Dr. Jeffrey Chi, Authorized Signatory
Date:02/24/2025